Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Clip Money Inc. Announces US$2,000,000 Convertible Note Financing
-
MediWound to Present at the 45th Annual TD Cowen Health Care Conference
-
Lincoln Educational Services Reports Strong Results for Fourth Quarter and Full Year 2024; Provides Outlook for Continued Strong Growth in 2025
-
Arcutis Announces Publication of Positive Data from INTEGUMENT-PED Trial Evaluating ZORYVE® (roflumilast) Cream 0.05% in Children 2 to 5 Years Old with Mild to Moderate Atopic Dermatitis in Pediatric
-
Gabelli Funds to Host Pump, Valve & Water Systems Symposium at the Harvard Club, New York City
-
Constellium Joins Industry Consortium for Lightweight Vehicle Chassis Innovation Project
-
LENZ Therapeutics to Participate in Upcoming Investor Conferences
-
PDS Biotech Announces Circulating Tumor DNA Results for Versamune® HPV in IMMUNOCERV Trial Published in Clinical Cancer Research
-
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
-
Bastion Insights Empowers Organizations with Research Bootcamps
-
KnowBe4 Secures Leadership Position in Frost Radar™: Human Risk Management, 2024 Report
-
Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference
-
STMicroelectronics Announces Status of Common Share Repurchase Program
-
ASML reports transactions under its current share buyback program
-
Alvotech to Report Full Year Financial Results for 2024 on March 26, 2025, and Hosts Conference Call on March 27, 2025, at 8:00 am ET
-
Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients
-
Study: Brain Exercise Lowers Fatigue Symptoms in Multiple Sclerosis
-
Kaldvik AS (KLDVK): Q4 2024 Webcast results 26 February 2025 at 11:00 (CET)
-
-
Kepler Cuts Audience Development Time in Half with Kip Personas
-
EuroDry Ltd. Reports Results for the Year and Quarter Ended December 31, 2024
-
ElevateBio Announces Compelling Preclinical Data Demonstrating the Potential of LETI-101 as a Treatment for Huntington's Disease
-
ElevateBio Announces Compelling Preclinical Data Demonstrating the Potential of LETI-101 as a Treatment for Huntington's Disease
-
Algoma Steel Group to Participate in the BMO 34th Global Metals, Mining & Critical Minerals Conference
-
Plus Therapeutics Announces Leadership Appointments for its CNSide Diagnostics Subsidiary
-
Connexa Sports Technologies Inc. Signs Content Creation Agreement with TikTok for the Middle East and North Africa
-
Red Cat Holdings Proud to Announce Teal’s Black Widow™ and FlightWave’s Edge 130 Selected as Winners of the Blue UAS Refresh
-
Houston American Energy Corp. Enters Definitive Agreement to Acquire Abundia Global Impact Group, Expanding into Renewable Fuels and Chemicals
-
Algoma Steel Group to Participate in the BMO 34th Global Metals, Mining & Critical Minerals Conference
-
Werewolf Therapeutics Appoints Anil Singhal, Ph.D., to its Board of Directors
-
Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference
-
Allied Announces Renewal of Normal Course Issuer Bid
-
Form 8.3 - Team Internet Group Plc
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 21 02 2025] - (CGWL)
-
Form 8.3 - [ALLIANCE PHARMA PLC - 21 02 2025] - (CGWL)
-
Transactions in connection with share buyback programme
-
MPLAB® XC Unified Compiler Licenses Deliver Streamlined Software Management
-
Volaris Reports Financial Results for the Fourth Quarter 2024: Net Income of $46 million
-
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No
-
Notice of Annual General Meeting of Shareholders of Kaspi.kz
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Allegro MicroSystems Appoints Mike Doogue as President and Chief Executive Officer
-
BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
-
Nusano and Atomiq Collaborating to Develop Nuclear Battery Technologies
-
Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia
-
Capital City Bank Establishes Chief Banking Officer; Names New Chief Lending Officer
-
XORTX Commences Gout Program NDA Discussions with the FDA
-
Skye Bioscience to Participate in SXSW Session on Obesity
-
Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases
-
MEDIA ADVISORY: Papa Johns Canada to Present $73,411 Donation to Second Harvest
